0001078782-20-001012.txt : 20201228 0001078782-20-001012.hdr.sgml : 20201228 20201228123855 ACCESSION NUMBER: 0001078782-20-001012 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20201228 DATE AS OF CHANGE: 20201228 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: TAURIGA SCIENCES, INC. CENTRAL INDEX KEY: 0001142790 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 651102237 STATE OF INCORPORATION: FL FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-87657 FILM NUMBER: 201416771 BUSINESS ADDRESS: STREET 1: 555 MADISON AVENUE STREET 2: 5TH FLOOR SUITE 506 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 917-796-9926 MAIL ADDRESS: STREET 1: 555 MADISON AVENUE STREET 2: 5TH FLOOR SUITE 506 CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: Immunovative, Inc. DATE OF NAME CHANGE: 20120503 FORMER COMPANY: FORMER CONFORMED NAME: Novo Energies Corp DATE OF NAME CHANGE: 20090626 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC WINE AGENCIES INC DATE OF NAME CHANGE: 20040622 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GS Capital Partners, LLC CENTRAL INDEX KEY: 0001720125 IRS NUMBER: 821042853 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 110 WALL STREET STREET 2: SUITE 5-070 CITY: NEW YORK STATE: NY ZIP: 10005 BUSINESS PHONE: 212-419-8202 MAIL ADDRESS: STREET 1: 110 WALL STREET STREET 2: SUITE 5-070 CITY: NEW YORK STATE: NY ZIP: 10005 SC 13G 1 13g122820_sc13g.htm SCHEDULE 13G Schedule 13G

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

 

TAURIGA SCIENCES, INC.

(Name of Issuer)

 

Common Stock

(Title of Class of Securities)

 

87669X205

(CUSIP Number)

 

December 28, 2020

(Date of Event which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

[   ] Rule 13d-1(b)

[X] Rule 13d-1(c)

[   ] Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

CUSIP No. 87669X205

 

 

 

13G

1.

 

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

GS Capital Partners, LLC

82-1042853

 

 

 

2.

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(see instructions)

(a) [   ]

(b) [X]

 

 

 

3.

 

SEC USE ONLY

 

 

 

4.

 

CITIZENSHIP OR PLACE OF ORGANIZATION

 

New York

 

 

 

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

 

5.

 

SOLE VOTING POWER

21,645,465*

 

 

6.

 

SHARED VOTING POWER

0

 

 

7.

 

SOLE DISPOSITIVE POWER

21,645,465*

 

 

8.

 

SHARED DISPOSITIVE POWER

0

 

 

 

*Consists of Common Stock that the reporting person has the right to acquire by way of conversion of a security.

 

 

 

9.

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

21,645,465*

 

*Consists of Common Stock that the reporting person has the right to acquire by way of conversion of a security.

 

 

 

10.

 

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) [   ]

 

 

 

11.

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

9.9% based on the December 24th, 2020 Outstanding share count of 218,641,066

 

 

 

12.

 

TYPE OF REPORTING PERSON (see instructions)

OO

 

 

 

 

 

 

 

 

 

 

 

CUSIP No. 87669X205

 

 

 

13G

 

Item 1.

 

 

(a)

Name of Issuer

Tauriga Sciences, Inc.

 

 

 

 

(b)

Address of Issuer’s Principal Executive Offices

555 Madison Avenue

5th Floor

New York, NY 10022

 

Item 2.

 

 

(a)

Name of Person Filing

GS Capital Partners, LLC

 

 

 

 

(b)

Address of the Principal Office or, if none, residence

30 Washington St, Suite 5L, Brooklyn, NY 11201

 

 

 

 

(c)

Citizenship

New York LLC

 

 

 

 

(d)

Title of Class of Securities

Common Stock

 

 

 

 

(e)

CUSIP Number

87669X205

 

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

 

(a)

[   ]

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

 

 

 

 

 

(b)

[   ]

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

 

 

 

 

 

(c)

[   ]

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

 

 

 

 

 

(d)

[   ]

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

 

 

 

 

 

(e)

[   ]

An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

 

 

 

 

 

(f)

[   ]

An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

 

 

 

 

 

(g)

[   ]

A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

 

 

 

 

 

(h)

[   ]

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

 

 

 

 

 

(i)

[   ]

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

 

 

 

 

 

(j)

[   ]

Group, in accordance with §240.13d-1(b)(1)(ii)(J).

 

 

 

 

 

CUSIP No. 87669X205

 

 

 

13G

 

Item 4. Ownership.

 

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

 

(a)

Amount beneficially owned: 21,645,465*

 

 

 

 

 

(b)

Percent of class: 9.9%

 

 

 

 

 

(c)

Number of shares as to which the person has:

 

 

 

 

 

 

(i)

Sole power to vote or to direct the vote 21,645,465*

 

 

 

 

 

 

(ii)

Shared power to vote or to direct the vote 0

 

 

 

 

 

 

(iii)

Sole power to dispose or to direct the disposition of 21,645,465*

 

 

 

 

 

 

(iv)

Shared power to dispose or to direct the disposition of 0

 

*Consists of Common Stock that the reporting person has the right to acquire by way of conversion of a security.

 

 

Item 5. Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [   ]

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

 

Item 8. Identification and Classification of Members of the Group.

 

Item 9. Notice of Dissolution of Group.

 

Item 10. Certification.

 

 

(a)

The following certification shall be included if the statement is filed pursuant to §240.13d-1(b):

 

 

 

 

 

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

 

 

 

 

(b)

The following certification shall be included if the statement is filed pursuant to §240.13d-1(c):

 

 

 

 

 

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

 

 

 

 

 

 

CUSIP No. 87669X205

 

 

 

13G

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

12/24/2020

Date

 

/s/ Gabriel Sayegh

Signature

 

President

Name/Title